A new state-of-the-art hospital has been completed on the Cambridge biomedical campus.

Skanska delivered the Royal Papworth Hospital, which will house five operating theatres, five catheter laboratories (for non-surgical procedures) and two hybrid theatres. Approximately 310 beds will be available for patients, including a 46-bed critical care unit, with most patients having their own single, en-suite rooms.

Other key features include a specialist air filtering system in the hospital's cystic fibrosis department to minimise the spread of airborne infections, and a link corridor to the adjacent Addenbrooke's Hospital to support the transfer of patients needing treatment in the two hospitals.


The new facility will see Royal Papworth staff move from their existing hospital in Papworth Everard. It will continue to enable staff to deliver excellent care to patients suffering from heart and lung disease.

Stephen Posey, Chief Executive at Royal Papworth Hospital NHS Foundation Trust, said: "It is incredibly exciting to be able to walk through the hospital without hard hats and high-vis jackets and really imagine this impressive building as a fully-functioning heart and lung hospital. After many years of planning, we are now just months away from moving in and starting to realise the huge benefits that the new building and its location on the Cambridge Biomedical Campus will bring for our patients and staff."

Charlie Norris, Project Director for Skanska, added: "We're delighted to hand over the building to our customer. We look forward to watching its transformation with the latest medical equipment into a world-class facility. The thousands of hours of work by our people and the supply chain will leave a positive lasting legacy for Cambridge, the UK and beyond."

Royal Papworth will move all of its clinical services to the new hospital during a three-week move period from 23 April 2019. 

(CM/MH)